Orthopediatrics Corp (NASDAQ:KIDS) Sees Significant Growth in Short Interest
Orthopediatrics Corp (NASDAQ:KIDS) saw a significant increase in short interest in the month of September. As of September 30th, there was short interest totalling 1,070,000 shares, an increase of 5.9% from the August 30th total of 1,010,000 shares. Currently, 12.1% of the shares of the company are short sold. Based on an average trading volume of 85,300 shares, the short-interest ratio is currently 12.5 days.
Several hedge funds have recently modified their holdings of KIDS. Calamos Advisors LLC bought a new stake in Orthopediatrics during the second quarter worth $2,373,000. Russell Investments Group Ltd. acquired a new position in shares of Orthopediatrics during the second quarter worth $2,055,000. Prospect Capital Advisors LLC increased its holdings in shares of Orthopediatrics by 11.6% during the second quarter. Prospect Capital Advisors LLC now owns 230,100 shares of the company’s stock worth $8,974,000 after buying an additional 24,000 shares in the last quarter. Allianz Asset Management GmbH increased its holdings in shares of Orthopediatrics by 2.9% during the second quarter. Allianz Asset Management GmbH now owns 137,068 shares of the company’s stock worth $5,346,000 after buying an additional 3,833 shares in the last quarter. Finally, Riverbridge Partners LLC increased its holdings in shares of Orthopediatrics by 41.3% during the third quarter. Riverbridge Partners LLC now owns 513,070 shares of the company’s stock worth $18,091,000 after buying an additional 149,855 shares in the last quarter. Institutional investors and hedge funds own 48.37% of the company’s stock.
Shares of KIDS stock traded up $0.73 during trading on Thursday, hitting $37.01. The company had a trading volume of 39,100 shares, compared to its average volume of 76,178. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.75 and a current ratio of 2.53. The firm has a market capitalization of $531.10 million, a P/E ratio of -38.38 and a beta of 0.21. The stock’s 50-day moving average price is $35.03 and its 200 day moving average price is $37.21. Orthopediatrics has a one year low of $25.11 and a one year high of $47.82.
Several brokerages recently issued reports on KIDS. BidaskClub cut Orthopediatrics from a “buy” rating to a “hold” rating in a research note on Friday, September 27th. Zacks Investment Research upgraded Orthopediatrics from a “hold” rating to a “buy” rating and set a $37.00 price target for the company in a research note on Thursday, October 10th. ValuEngine cut Orthopediatrics from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Finally, Needham & Company LLC began coverage on Orthopediatrics in a research note on Wednesday, June 19th. They issued a “buy” rating and a $53.00 price target for the company. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $44.50.
Orthopediatrics Company Profile
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.
Further Reading: Is the QQQ ETF safe?
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.